Bharat Biotech, WHO To Meet Over Covaxin Emergency Use Listing On June 23

The World Health Organisation has accepted Bharat Biotech's Expression of Interest for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting.

In a major boost for Bharat Biotech, the World Health Organisation (WHO) has accepted its Expression of Interest (EoI) for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23, a step that will take the vaccine maker closer to a WHO emergency use listing (EUL). Though the meeting will not be a detailed review on the product, the vaccine maker will have an opportunity to submit a summary on overall quality of the jab, according to the WHO. The information was provided in the WHO website in the Status of COVID-19 Vaccines within WHO EUL-PQ evaluation process document. Bharat Biotech had said last month that it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for emergency use listing during July-September.